Stoke Therapeutics
STOK
STOK
97 hedge funds and large institutions have $680M invested in Stoke Therapeutics in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
49.74% less ownership
Funds ownership: 104.81% → 55.07% (-50%)
54% less capital invested
Capital invested by funds: $1.49B → $680M (-$811M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
97
Holding in Top 10
–
Calls
$1.72M
Puts
$1.09M
Top Buyers
| 1 | +$9.99M | |
| 2 | +$5.3M | |
| 3 | +$2.77M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.62M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.18M |
Top Sellers
| 1 | -$25.1M | |
| 2 | -$14.2M | |
| 3 | -$7.94M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$5.37M |
| 5 |
BlackRock
New York
|
-$4.87M |